» Articles » PMID: 28936051

Bacterial Contamination of Multi-dose Eye Drops at Ophthalmology Department, University of Gondar, Northwest Ethiopia

Overview
Specialty Ophthalmology
Date 2017 Sep 23
PMID 28936051
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Ophthalmic solutions used for both diagnostic and therapeutic purposes were found to be contaminated with bacteria pathogens and caused serious ocular infections such as keratitis and endophthalmitis. The objective was to assess the magnitude and pattern of bacterial contamination of multi-dose ophthalmic medications and investigate the drug susceptibility pattern of the isolates in the Department of Ophthalmology at Gondar University Teaching Hospital.

Methods: A total of 100 ophthalmic medications in-use by patients and eye-care workers have been taken and cultured for potential bacterial contamination in the Microbiology Department after 1 week and >1 week of use. The dropper tip and the residual eye medications were examined for contamination. The contaminating bacteria were identified using a standard procedure and drug susceptibility testing to selected antimicrobial agents was done.

Results: Eleven ophthalmic medications were contaminated by different bacterial species with a prevalence of 11%. Multi-use and longer duration of use of eye medications were associated with higher rate of contamination. The contamination level ranges from 0% for antibiotics, 20% for local anesthetics, and 40% for povidone iodine. Among bacteria identified, and coagulase-negative species were resistant to methicillin while others were sensitive to the antibiotics tested.

Conclusion: The prevalence of contamination was low, but methicillin-resistant was a potential risk. It is recommended that the Department of Ophthalmology should design set of rules about duration of use and safe handling of ophthalmic medications by the staff and patients.

Citing Articles

Development of a conjunctival contact-type drug delivery device for latanoprost using hyaluronic acid.

Lee S, Jung M, Park C Drug Deliv. 2025; 32(1):2459775.

PMID: 39902753 PMC: 11795754. DOI: 10.1080/10717544.2025.2459775.


Evaluating and Managing the Microbial Contamination of Eye Drops: A Two-Phase Hospital-Based Study.

Roquefeuil L, Iskandar K, Roques C, Marchin L, Guittard M, Poupet H Pharmaceutics. 2024; 16(7).

PMID: 39065630 PMC: 11279954. DOI: 10.3390/pharmaceutics16070933.


Achieving net-zero in the dry eye disease care pathway.

Latham S, Williams R, Grover L, Rauz S Eye (Lond). 2023; 38(5):829-840.

PMID: 37957294 PMC: 10965955. DOI: 10.1038/s41433-023-02814-3.


How Ophthalmologists Can Decarbonize Eye Care: A Review of Existing Sustainability Strategies and Steps Ophthalmologists Can Take.

Sherry B, Lee S, Ramos Cadena M, Laynor G, Patel S, dellaBadia Simon M Ophthalmology. 2023; 130(7):702-714.

PMID: 36889466 PMC: 10293062. DOI: 10.1016/j.ophtha.2023.02.028.


Highlighting the Microbial Contamination of the Dropper Tip and Cap of In-Use Eye Drops, the Associated Contributory Factors, and the Risk of Infection: A Past-30-Years Literature Review.

Iskandar K, Marchin L, Kodjikian L, Rocher M, Roques C Pharmaceutics. 2022; 14(10).

PMID: 36297611 PMC: 9611205. DOI: 10.3390/pharmaceutics14102176.


References
1.
Mayo M, Schlitzer R, Ward M, Wilson L, Ahearn D . Association of Pseudomonas and Serratia corneal ulcers with use of contaminated solutions. J Clin Microbiol. 1987; 25(8):1398-400. PMC: 269233. DOI: 10.1128/jcm.25.8.1398-1400.1987. View

2.
Brudieu E, Duc D, Masella J, Croize J, Valence B, Meylan I . [Bacterial contamination of multi-dose ocular solutions. A prospective study at the Grenoble Teaching Hospital]. Pathol Biol (Paris). 2000; 47(10):1065-70. View

3.
Whitcher J . Corneal ulceration. Int Ophthalmol Clin. 1990; 30(1):30-2. View

4.
Livingstone D, Hanlon G, Dyke S . Evaluation of an extended period of use for preserved eye drops in hospital practice. Br J Ophthalmol. 1998; 82(5):473-5. PMC: 1722611. DOI: 10.1136/bjo.82.5.473. View

5.
Nentwich M, Kollmann K, Meshack J, Ilako D, Schaller U . Microbial contamination of multi-use ophthalmic solutions in Kenya. Br J Ophthalmol. 2007; 91(10):1265-8. PMC: 2000994. DOI: 10.1136/bjo.2007.116897. View